Pace Diagnostics Revenue and Competitors
Estimated Revenue & Valuation
- Pace Diagnostics's estimated annual revenue is currently $1.4M per year.
- Pace Diagnostics's estimated revenue per employee is $155,000
Employee Data
- Pace Diagnostics has 9 Employees.
- Pace Diagnostics grew their employee count by -10% last year.
Pace Diagnostics's People
Name | Title | Email/Phone |
---|---|---|
1 | Chief Operating Officer, Co-Founder | Reveal Email/Phone |
2 | Founder/President/CEO | Reveal Email/Phone |
Pace Diagnostics Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $4.4M | 57 | -8% | $53M | N/A |
#2 | $21.2M | 137 | -26% | $110M | N/A |
#3 | $0.9M | 6 | 0% | N/A | N/A |
#4 | $2.3M | 15 | 15% | N/A | N/A |
#5 | $1.6M | 10 | -17% | N/A | N/A |
#6 | $0.7M | 9 | 50% | N/A | N/A |
#7 | $11.5M | 74 | -12% | N/A | N/A |
#8 | $0.4M | 275 | 10% | $236.7M | N/A |
#9 | $4M | 51 | -74% | $160M | N/A |
#10 | $2.3M | 15 | 15% | N/A | N/A |
What Is Pace Diagnostics?
Pace Diagnostics is an emerging biotechnology company focused on the research, development, licensing, manufacturing and marketing of cutting-edge diagnostics. Formed, based on the culmination of decades of basic and applied research, supported by grants and contracts from the US Federal Government, our vision is to create breakthrough point-of-care (POC) diagnostics to revolutionize improvements in healthcare for better living. Through our novel, high-throughput platform, and potent biomarkers, we are developing a comprehensive portfolio of POC diagnostics, with our lead developments in Tuberculosis and the early detection of lung cancer.
keywords:N/AN/A
Total Funding
9
Number of Employees
$1.4M
Revenue (est)
-10%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $1.6M | 10 | 0% | N/A |
#2 | $1M | 11 | 10% | N/A |
#3 | $1.2M | 14 | -7% | N/A |
#4 | $1.2M | 14 | 0% | N/A |
#5 | $1.8M | 14 | -7% | N/A |